Next Article in Journal
Associations of TIMP-3 Genetic Polymorphisms with EGFR Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients
Next Article in Special Issue
Mitochondrial Transfer in Cancer: A Comprehensive Review
Previous Article in Journal
Osmosis-Driven Water Transport through a Nanochannel: A Molecular Dynamics Simulation Study
Previous Article in Special Issue
Aspirin Induces Mitochondrial Ca2+ Remodeling in Tumor Cells via ROS‒Depolarization‒Voltage-Gated Ca2+ Entry
 
 
Review
Peer-Review Record

Cardiolipin, the Mitochondrial Signature Lipid: Implication in Cancer

Int. J. Mol. Sci. 2020, 21(21), 8031; https://doi.org/10.3390/ijms21218031
by Seyedeh Tayebeh Ahmadpour, Karine Mahéo, Stéphane Servais, Lucie Brisson and Jean-François Dumas *
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2020, 21(21), 8031; https://doi.org/10.3390/ijms21218031
Submission received: 29 September 2020 / Revised: 20 October 2020 / Accepted: 26 October 2020 / Published: 28 October 2020
(This article belongs to the Special Issue Mitochondrial Functions, Alterations and Dynamics in Cancer)

Round 1

Reviewer 1 Report

The manuscript is a ontime revision of the cardiolipin relevant findings. This findings are necessary for the management of future therapies that target mitochondrial signalling pathways in cancer patients. The work is well organised, the reference are up to date, but need some corection. The english language needs some minor spelling correction.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Please see attached report

Comments for author File: Comments.pdf

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop